128 related articles for article (PubMed ID: 29668675)
1. Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
Sun X; Stewart DA; Sandhu R; Kirk EL; Pathmasiri WW; McRitchie SL; Clark RF; Troester MA; Sumner SJ
PLoS One; 2018; 13(4):e0193792. PubMed ID: 29668675
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.
Brauer HA; Makowski L; Hoadley KA; Casbas-Hernandez P; Lang LJ; Romàn-Pèrez E; D'Arcy M; Freemerman AJ; Perou CM; Troester MA
Clin Cancer Res; 2013 Feb; 19(3):571-85. PubMed ID: 23236214
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features.
Haakensen VD; Lingjaerde OC; Lüders T; Riis M; Prat A; Troester MA; Holmen MM; Frantzen JO; Romundstad L; Navjord D; Bukholm IK; Johannesen TB; Perou CM; Ursin G; Kristensen VN; Børresen-Dale AL; Helland A
BMC Med Genomics; 2011 Nov; 4():77. PubMed ID: 22044755
[TBL] [Abstract][Full Text] [Related]
4. A joint analysis of metabolomics and genetics of breast cancer.
Tang X; Lin CC; Spasojevic I; Iversen ES; Chi JT; Marks JR
Breast Cancer Res; 2014 Aug; 16(4):415. PubMed ID: 25091696
[TBL] [Abstract][Full Text] [Related]
5. Glutamate enrichment as new diagnostic opportunity in breast cancer.
Budczies J; Pfitzner BM; Györffy B; Winzer KJ; Radke C; Dietel M; Fiehn O; Denkert C
Int J Cancer; 2015 Apr; 136(7):1619-28. PubMed ID: 25155347
[TBL] [Abstract][Full Text] [Related]
6. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
[TBL] [Abstract][Full Text] [Related]
8. Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer.
Dexter TJ; Sims D; Mitsopoulos C; Mackay A; Grigoriadis A; Ahmad AS; Zvelebil M
BMC Syst Biol; 2010 Sep; 4():127. PubMed ID: 20825665
[TBL] [Abstract][Full Text] [Related]
9. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.
Budczies J; Denkert C; Müller BM; Brockmöller SF; Klauschen F; Györffy B; Dietel M; Richter-Ehrenstein C; Marten U; Salek RM; Griffin JL; Hilvo M; Orešič M; Wohlgemuth G; Fiehn O
BMC Genomics; 2012 Jul; 13():334. PubMed ID: 22823888
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Footprints and Molecular Subtypes in Breast Cancer.
Cappelletti V; Iorio E; Miodini P; Silvestri M; Dugo M; Daidone MG
Dis Markers; 2017; 2017():7687851. PubMed ID: 29434411
[TBL] [Abstract][Full Text] [Related]
12. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
Johnson KC; Houseman EA; King JE; Christensen BC
Breast Cancer Res; 2017 Jul; 19(1):81. PubMed ID: 28693600
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics biomarkers of frailty in elderly breast cancer patients.
Corona G; Polesel J; Fratino L; Miolo G; Rizzolio F; Crivellari D; Addobbati R; Cervo S; Toffoli G
J Cell Physiol; 2014 Jul; 229(7):898-902. PubMed ID: 24659054
[TBL] [Abstract][Full Text] [Related]
14. Nonfamilial breast cancer subtypes.
Ringnér M; Staaf J; Jönsson G
Methods Mol Biol; 2013; 973():279-95. PubMed ID: 23412797
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of breast cancer pathological phenotypes.
Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
[TBL] [Abstract][Full Text] [Related]
17. Vascular density of histologically benign breast tissue from women with breast cancer: associations with tissue composition and tumor characteristics.
Fuller AM; Olsson LT; Midkiff BR; Kirk EL; McNaughton KK; Calhoun BC; Troester MA
Hum Pathol; 2019 Sep; 91():43-51. PubMed ID: 31271812
[TBL] [Abstract][Full Text] [Related]
18. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
[TBL] [Abstract][Full Text] [Related]
19. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
